Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis

Background. TNF-α inhibitors have shown to be effective in reducing disease activity and improving the quality of life. Due to the high costs associated with acquisition of this treatment, this study was undertaken to evaluate the ICER of TNF-α antagonists (etanercept, adalimumab, and infliximab) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Cynthia, Coleiro, Bernard, Zarb Adami, Maurice, Azzopardi, Lilian M., Serracino Inglott, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845242/
https://www.ncbi.nlm.nih.gov/pubmed/24324915
http://dx.doi.org/10.1155/2013/581409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845242/
https://www.ncbi.nlm.nih.gov/pubmed/24324915
http://dx.doi.org/10.1155/2013/581409

Ejemplares similares